Medicare Enrolled

Dr. Kristine Kucera, PA

Physician Assistant · Melissa, TX
Speaking/Promotional
3041 WASHINGTON DRIVE, Melissa, TX 75454
4695810599
In practice since 2007 (18 years)
NPI: 1699970368 verify on NPPES ↗
High
DATA COVERAGE
Data in 3 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Kucera from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Kucera? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Kucera

Dr. Kristine Kucera is a physician assistant in Melissa, TX, with 18 years of NPI registration.

Between the years covered by Open Payments, Dr. Kucera received a total of $610,182 from 34 pharmaceutical and/or device companies across 1584 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in physician assistant. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Kucera is High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 18 years in practice $610,182 industry payments

Industry Payment Transparency

Open Payments through 2024 ↗
$610,182
Total received (2021-2024)
Avg $152,546/year across 4 years
Top 0% in TX for physician assistant
34
Companies
1,584
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$548,638 (89.9%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$54,877 (9.0%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$6,667 (1.1%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$165,029
2023
$221,341
2022
$162,059
2021
$61,754

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$192,647
E.R. Squibb & Sons, L.L.C.
$110,628
Janssen Biotech, Inc.
$72,646
LEO Pharma Inc.
$51,045
Amgen Inc.
$47,605
UCB, Inc.
$30,366
SUN PHARMACEUTICAL INDUSTRIES INC.
$26,749
Sun Pharmaceutical Industries Inc.
$24,942
AbbVie Inc.
$15,566
PFIZER INC.
$8,882
Arcutis Biotherapeutics, Inc.
$5,980
Incyte Corporation
$5,076
Janssen Scientific Affairs, LLC
$4,973
Pfizer Inc.
$3,370
NOVARTIS PHARMACEUTICALS CORPORATION
$2,493
Novartis Pharmaceuticals Corporation
$2,049
Ortho Dermatologics, a division of Bausch Health US, LLC
$1,500
Regeneron Healthcare Solutions, Inc.
$884
Lilly USA, LLC
$659
Almirall LLC
$485
Galderma Laboratories, L.P.
$482
GENZYME CORPORATION
$353
Dermavant Sciences, Inc.
$343
VYNE Pharmaceuticals Inc.
$112
Biofrontera Inc.
$86
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$70
EPI Health, LLC
$40
MAYNE PHARMA INC.
$36
Boehringer Ingelheim Pharmaceuticals, Inc.
$33
SANOFI-AVENTIS U.S. LLC
$24
Allergan, Inc.
$17
DERMIRA, INC.
$16
Bausch Health US, LLC
$14
Nabriva Therapeutics, plc
$12
Top 3 companies account for 61.6% of total payments
Associated products mentioned in payments ›
ADBRY · AKLIEF · AMELUZ · ARAZLO · Absorica LD · BLU-U · BOTOX · Bimzelx · CIBINQO · CLODERM · COSENTYX · CYLTEZO · Cimzia · DUOBRII · DUPIXENT · ENSTILAR · EPSOLAY · EUCRISA · Enbrel · FINACEA · HUMIRA · ILUMYA · Ilumya · JUBLIA · Klisyri · LIBTAYO · OLUMIANT · OPZELURA · ORACEA · Otezla · QBREXZA · REMICADE · RINVOQ · SILIQ · SKYRIZI · SPEVIGO · Seysara · Sivextro · Sotyktu · TALTZ · TARGRETIN · TREMFYA · VTAMA · Winlevi · ZILXI · Zoryve
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (90%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in physician assistant and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 0% for physician assistant in TX.

Looking for a physician assistant in Melissa?
Compare physician assistants in the Melissa area by procedure volume, costs, and industry payment transparency.
Browse physician assistants nearby

Geographic Context

Physician assistants within 10 mi
603
Per 100K population
54.0
County median income
$117,588
Nearest hospital
BAYLOR SCOTT AND WHITE MEDICAL CENTER MCKINNEY
4.8 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data — No data N/A
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 3 of 4 available federal datasets, with a Data Coverage level of High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Kucera is a physician assistant, with speaking/promotional industry engagement in the top 0% of TX peers, with 18 years of NPI registration.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Does Dr. Kucera receive payments from pharmaceutical companies?
Yes. Dr. Kucera received a total of $610,182 from 34 companies across 1,584 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
What does Data Coverage mean?
Data Coverage (currently High for Dr. Kucera) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →